Bank of New York Mellon’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $878K | Sell |
31,739
-90,120
| -74% | -$2.49M | ﹤0.01% | 3185 |
|
2025
Q1 | $2.71M | Sell |
121,859
-192
| -0.2% | -$4.26K | ﹤0.01% | 2530 |
|
2024
Q4 | $2.41M | Buy |
122,051
+30,382
| +33% | +$601K | ﹤0.01% | 2665 |
|
2024
Q3 | $2.29M | Sell |
91,669
-23,474
| -20% | -$587K | ﹤0.01% | 2685 |
|
2024
Q2 | $2.15M | Buy |
115,143
+2,563
| +2% | +$47.9K | ﹤0.01% | 2756 |
|
2024
Q1 | $2.22M | Sell |
112,580
-20,973
| -16% | -$414K | ﹤0.01% | 2709 |
|
2023
Q4 | $2.34M | Sell |
133,553
-13,015
| -9% | -$228K | ﹤0.01% | 2744 |
|
2023
Q3 | $2.55M | Buy |
146,568
+17,790
| +14% | +$309K | ﹤0.01% | 2675 |
|
2023
Q2 | $1.81M | Buy |
128,778
+828
| +0.6% | +$11.7K | ﹤0.01% | 2895 |
|
2023
Q1 | $1.38M | Buy |
127,950
+603
| +0.5% | +$6.49K | ﹤0.01% | 2998 |
|
2022
Q4 | $1.91M | Buy |
127,347
+1,819
| +1% | +$27.2K | ﹤0.01% | 2877 |
|
2022
Q3 | $1.61M | Buy |
125,528
+4,891
| +4% | +$62.8K | ﹤0.01% | 2971 |
|
2022
Q2 | $1.17M | Sell |
120,637
-16,364
| -12% | -$159K | ﹤0.01% | 3134 |
|
2022
Q1 | $1.36M | Buy |
137,001
+3,095
| +2% | +$30.8K | ﹤0.01% | 3128 |
|
2021
Q4 | $1.58M | Sell |
133,906
-1,091
| -0.8% | -$12.8K | ﹤0.01% | 3133 |
|
2021
Q3 | $1.54M | Buy |
134,997
+3,638
| +3% | +$41.4K | ﹤0.01% | 3155 |
|
2021
Q2 | $1.83M | Sell |
131,359
-3,056
| -2% | -$42.6K | ﹤0.01% | 3037 |
|
2021
Q1 | $2.49M | Sell |
134,415
-2,448
| -2% | -$45.3K | ﹤0.01% | 2799 |
|
2020
Q4 | $2.42M | Buy |
136,863
+45,909
| +50% | +$811K | ﹤0.01% | 2732 |
|
2020
Q3 | $1.39M | Buy |
90,954
+13,437
| +17% | +$206K | ﹤0.01% | 2906 |
|
2020
Q2 | $1.98M | Buy |
77,517
+29,295
| +61% | +$746K | ﹤0.01% | 2688 |
|
2020
Q1 | $747K | Buy |
48,222
+1,998
| +4% | +$31K | ﹤0.01% | 3160 |
|
2019
Q4 | $512K | Sell |
46,224
-5,989
| -11% | -$66.3K | ﹤0.01% | 3582 |
|
2019
Q3 | $445K | Sell |
52,213
-4,158
| -7% | -$35.4K | ﹤0.01% | 3591 |
|
2019
Q2 | $764K | Buy |
56,371
+9,427
| +20% | +$128K | ﹤0.01% | 3373 |
|
2019
Q1 | $848K | Buy |
46,944
+26,374
| +128% | +$476K | ﹤0.01% | 3285 |
|
2018
Q4 | $578K | Buy |
20,570
+3,499
| +20% | +$98.3K | ﹤0.01% | 3408 |
|
2018
Q3 | $435K | Buy |
+17,071
| New | +$435K | ﹤0.01% | 3702 |
|